abstract |
The present invention relates to compounds of formula (I) n n n n n n n n n n wherein A is C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -hydroxyalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halo-alkenyl, C 3 -C 6 -cycloalkyl, aryl-C 1 -C 4 -alkyl, aryl-C 2 -C 4 -alkenyl, aryl or hetaryl, is a single or double bond; X 1 and X 2 are N, CR x1 , NR x2 , or CR x3 R x4 ; R x1 , R x3 and R x4 are H, halogen, CN, NO 2 , C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylcarbonyl, etc. or two geminal radicals R x3 and R x4 together with the carbon atom to which they are bound may form a carbonyl group or a 3- to 6-membered carbocyclic or heterocyclic spiro-annulated ring; R x2 is hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -haloalkyl, etc.; or two vicinal radicals R x1 , R x2 , R x3 or R x4 together with X 1 and X 2 form a five- or six-membered carbocyclic or heterocyclic fused ring; Y 1 , Y 2 and Y 3 are N or CR y ; R y is H, halogen, CN, NO 2 , C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -haloalkyl, etc.; wherein a maximum of 3 of the radicals X 1 , X 2 , Y 1 , Y 2 and Y 3 are selected from NR x1 and N; R 1 is hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -hydroxyalkyl, C 1 -C 6 -haloalkyl, etc.; R 2 is C 1 -C 4 -alkyl or C 1 -C 4 -haloalkyl; n is 0, 1 or 2; physiologically tolerated acid addition salts and the N-oxides thereof, pharmaceutical composition comprising them, a method for treating medical disorders selected from diseases of the central nervous system, addiction diseases or obesity, said method comprising administering an effective amount of such compounds to a subject in need and the use of such a compound for preparing a pharmaceutical compositions. |